Comparison of the Accessory Activity of Murine Peritoneal Cavity Macrophage Derived Dendritic Cells and Peritoneal Cavity Macrophages in a Mixed Lymphocyte Reaction.

DOI Web Site Web Site PubMed 被引用文献3件 参考文献61件
  • MAKALA Levi H. C.
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine
  • NISHIKAWA Yoshifumi
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine
  • KAMADA Takenori
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine
  • SUZUKI Hiroshi
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine
  • XUAN Xuenan
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine
  • IGARASHI Ikuo
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine
  • NAGASAWA Hideyuki
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine

この論文をさがす

抄録

A detailed comparison of the accessory cell activities was carried out among murine peritoneal cavity macrophages (PEC-MΦ), peritoneal cavity macrophages stimulated with granulocyte-macrophage colony stimulating factor (GM-CSF) plus interleukin 4 (IL-4), the most popular cytokine combination widely used to generate dendritic cells (DC) and peritoneal cavity macrophage-derived DC (PEC-DC) using a two-way mixed lymphocyte reaction (MLR). All the cell types used efficiently induced statistically significant naïve T cell proliferation at all culture time points and responder:stimulator ratios used. However, marked differences were noted in the magnitude of the proliferative responses. These variations may be attributed to the intensity of expression of MHC class II glycoproteins, as well as the actual numbers of MHC class II+ cells.

収録刊行物

被引用文献 (3)*注記

もっと見る

参考文献 (61)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ